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Appropriate selection of patients with atherosclerotic
renovascular disease (ARVD) for revascularization might be
improved if accurate non-invasive investigations were used
to assess severity of pre-existing parenchymal damage. The
purpose of this study was to evaluate the associations
between magnetic resonance imaging (MRI)-measured renal
morphological parameters and single-kidney glomerular
filtration rate (GFR) in ARVD. Three-dimensional (3D)-MRI was
performed on 35 ARVD patients. Renal bipolar length (BL),
parenchymal volume, parenchymal (PT), and cortical
thicknesses (CT) were measured in 65 kidneys. Thirteen
kidneys were supplied by normal vessels, 13 had insignificant
(o50%) renal artery stenosis (RAS), 33 significant (X50%)
RAS, and six complete vessel occlusion. All patients
underwent radioisotopic measurement of single-kidney GFR
(isoSK-GFR). Overall, 3D parameters such as parenchymal
volume were better correlates of isoSK-GFR (r¼ 0.86,
Po0.001) than BL (r¼ 0.78, Po0.001), PT (r¼ 0.63, Po0.001)
or CT (r¼ 0.60, Po0.001). Kidneys with X50% RAS did show
significant reduction in mean CT compared to those supplied
by normal vessel (5.6771.63 vs 7.2871.80 mm, P¼ 0.002;
22.1% reduction) and an even greater loss of parenchymal
volume (120.65747.15 vs 179.24786.90 ml, Po0.001; 32.7%
reduction) with no significant reduction in BL. In a proportion
of X50% RAS kidneys, a disproportionately high
parenchymal volume to isoSK-GFR was observed supporting
a concept of ‘hibernating parenchyma’. 3D parameters of
parenchymal volume are stronger correlates of isoSK-GFR
than two-dimensional measures of BL, PT or CT. 3D
morphological evaluation together with isoSK-GFR might be
useful in aiding patient selection for renal revascularization.
Kidneys with increased parenchymal volume to SK-GFR might
represent a subgroup with the potential to respond
beneficially to angioplasty.
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Atherosclerotic renovascular disease (ARVD) is commonly
associated with hypertension,1 chronic, and end-stage renal
disease,2,3 and various cardiovascular pathologies such as
coronary artery disease and cardiac failure.4,5 Renal revascu-
larization procedures are widely used in an attempt to modify
the natural history of some of these conditions,6 but renal
functional outcomes are variable and often unpredictable in
individual patients,7–9 reflecting the heterogeneous renal
injury responsible for the renal dysfunction in ARVD.10–14
Appropriate patient selection for revascularization would be
improved if accurate non-invasive investigations were used to
assess the degree of pre-existing renal parenchymal damage,
as these might help predict the clinical response to
angioplasty in the kidney with renal artery stenosis (RAS).
However, there is currently no consensus regarding the most
useful investigations, and where predictive benefits have been
demonstrated with certain techniques (e.g. measurement of
resistive index with Doppler ultrasound15), these have not
been widely utilized.
Analysis of renal morphology, most often by simple
ultrasound measurement of renal bipolar length, is the most
common means of estimating the extent of parenchymal
damage in RAS.16,17 More detailed renal morphological
parameters, such as renal volume and the thickness of the
total parenchyma or renal cortex, have been used to predict
overall renal function in normal individuals and in those with
chronic renal disease.18–20 Cortical thickness and cortical area
have been shown to predict the presence of unilateral RAS
with far greater sensitivity and accuracy than renal bipolar
length in patients with early ARVD or fibromuscular
dysplasia.21,22 Despite RAS frequently being unilateral, no
studies have attempted to relate measures of morphology to
individual kidney function, rather utilizing estimated glo-
merular filtration rate (GFR) as the functional parameter,
which calculates global rather than individual kidney
function.
Gadolinium-enhanced magnetic resonance (MR) angio-
graphy (MRA) is becoming the method of choice for
investigation of RAS as it is non-invasive and it avoids the
risks of contrast nephropathy that may complicate other
contrast radiographic techniques,23 and detailed assessment
of renal morphology can be acquired during the same MRA
study.24 We therefore examined the association of renal
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bipolar length, parenchymal volume, and cortical thickness
measured with gadolinium-enhanced magnetic resonance
imaging (MRI) with radioisotopic single-kidney GFR (isoSK-
GFR) in patients with ARVD.
RESULTS
During the recruitment period, 35 patients with ARVD were
investigated. Two patients were previously known to have
single kidneys. There was one patient who had bilateral
multiple cortical infarcts, which precluded accurate measure-
ment of cortical thickness and therefore was excluded from
analysis. Another patient had a severely atrophic kidney with
multiple large degenerative cysts and this kidney was not
included in the data analysis. Hence, a total of 65 kidneys
were studied. The mean patient age was 70.377.4 years
(range 50–81.1 years), and 24 were male and 10 female. MRA
showed that 13 kidneys were supplied by normal vessels, 13
by vessels with insignificant RAS, 33 by significant RAS, and
six had complete occlusion (RAO).
Correlation between renal morphology and isoSK-GFR
Fifity-nine kidneys were included in the correlation analysis
(RAO kidneys excluded). The relationships between bipolar
length (Figure 1), parenchymal volume (Figure 2), mean
parenchymal thickness (MPT) (Figure 3), mean cortical
thickness (MCT) (Figure 4), and isoSK-GFR are shown.
Overall, all morphological parameters were significantly
correlated with isoSK-GFR. Statistically, isoSK-GFR was
better correlated with renal parenchymal volume (r¼ 0.86,
Po0.001) than with bipolar length (r¼ 0.78, Po0.001) or
MPT and MCT (r¼ 0.63, Po0.001; r¼ 0.60, Po0.001,
respectively). IsoSK-GFR was more strongly correlated with
estimated cortical mass (r¼ 0.79, Po0.001) than with MCT
(Figure 5). In the subanalysis of normal vessel/insignificant
RAS kidneys, all morphological parameters were significantly
correlated with isoSK-GFR, with a stronger correlation with
parenchymal volume (r¼ 0.86, Po0.001) than bipolar length
(r¼ 0.81, Po0.001), MPT (r¼ 0.68, Po0.001) or MCT
(r¼ 0.73, Po0.001). Of the significant RAS kidneys, again
the strongest correlation with isoSK-GFR was seen with
parenchymal volume (r¼ 0.76, Po0.001) compared to
bipolar length (r¼ 0.65, Po0.001), but there was no
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Figure 1 | Correlation regression for bipolar length and isoSK-
GFR. Overall (n¼ 59), bipolar length was significantly correlated with
GFR (r¼ 0.78, Po0.001). Correlation subanalysis showed significant
correlations in the normal vessel/insignificant RAS (n¼ 26; r¼ 0.81,
Po0.001) and significant RAS (n¼ 33; r¼ 0.65, Po0.001) groups.
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Figure 2 | Correlation regression for renal parenchymal volume
and isoSK-GFR. Overall, renal volume was significantly related to
GFR (r¼ 0.86, Po0.001). Correlation subanalysis showed significant
correlations in the normal vessel/insignificant RAS (n¼ 26; r¼ 0.86,
Po0.001) and significant RAS (n¼ 33; r¼ 0.76, Po0.001) groups.
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Figure 3 | Correlation regression for parenchymal thickness and
isoSK-GFR. Overall, parenchymal thickness was significantly related
to GFR (r¼ 0.63, Po0.001). Correlation subanalysis showed significant
correlation in the normal vessel/insignificant RAS group (n¼ 26;
r¼ 0.68, Po0.001), but not in significant RAS group (n¼ 33;
r¼ 0.30, NS).
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correlation with other two-dimensional (2D) structural
parameters.
Renal morphology differences and severity of renovascular
disease
Overall, kidneys supplied by significant RAS were signifi-
cantly smaller in volume and had thinner cortices than those
supplied by normal vessels (Po0.001) (Table 1). Although
the mean bipolar length of kidneys with significant RAS was
approximately 10% smaller than mean lengths of kidneys in
the other two groups, this difference was not statistically
significant. When patient height, body mass index or surface
area was compared between the groups, no differences could
be identified.
Morphological and functional characteristics of small kidneys
Table 2 compares the morphological and functional char-
acteristics of kidneys with significant RAS grouped according
to whether they were small (bipolar length o8 cm, or of
preserved size). As expected, there were significant corre-
sponding reductions in volume, estimated cortical mass,
parenchymal, and medullary thicknesses in the kidneys with
smaller length, but six (54.5%) small kidneys had isoSK-GFR
X7 ml/min. The subanalysis of morphological parameters of
these 11 kidneys grouped according to function (isoSK-GFR
X7 ml/min group (n¼ 6) vs o7 ml/min group (n¼ 5))
showed no difference in all morphological characteristics
(Table 3) despite a significant difference in mean isoSK-GFR
between groups. The parenchymal volume to isoSK-GFR
ratio was used to estimate the degree of preservation of renal
tissue in relation to function. Although there was no overall
difference in this parameter between significant RAS and
normal vessel/insignificant RAS kidneys (Table 1), sub-
analysis of the 11 small kidneys in the significant RAS
group (Table 3) showed that kidneys with low GFR had
a significantly greater parenchymal volume: isoSK-GFR
(23.476.8 vs 7.673.0 ml per ml/min of GFR, P¼ 0.001).
DISCUSSION
Renal morphology should always be considered in the clinical
evaluation of patients with renovascular disease. The length
of a kidney is often used as an aid to the diagnosis of ARVD,
but also as a surrogate to estimate function and assess
viability. As renal functional outcomes are known to vary
after revascularization, it is important to focus attention on
improving the identification of those ARVD patients in
whom a beneficial change in renal function will accompany
revascularization. This study adds further to our under-
standing of which renal structural parameters are most
strongly linked to individual kidney function with three-
dimensional (3D) morphological parameters being more
closely related to individual kidney function than 2D
parameters.
Few previous investigators have studied renal morphology
in relation to individual kidney function in any form of renal
disease. Most studies have used estimated GFR calculated
from serum creatinine values, and this represents overall
bilateral rather than individual kidney function. We have
estimated the GFR of each kidney by a standard radioisotopic
method that is both accurate and reliable.26 In this study, we
noted that bipolar length, parenchymal volume, parenchymal,
and cortical thicknesses all showed some correlation with
isoSK-GFR. Although parenchymal and cortical thicknesses
are often used as markers in the assessment of intra-renal
damage, we found that cortical thickness was the weakest
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Figure 4 | Correlation regression for cortical thickness and isoSK-
GFR. Overall, cortical thickness was significantly related to GFR
(r¼ 0.60, Po0.001). Correlation subanalysis showed significant
correlation in the normal vessel/insignificant RAS group (n¼ 26;
r¼ 0.73, Po0.001), but not in significant RAS group (n¼ 33;
r¼ 0.15, NS).
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Figure 5 | Correlation regression for estimated cortical mass and
isoSK-GFR. Overall, cortical mass was significantly related to GFR
(r¼ 0.79, Po0.001). Correlation subanalysis showed significant
correlations in the normal vessel/insignificant RAS (n¼ 26; r¼ 0.83,
Po0.001) and significant RAS (n¼ 33; r¼ 0.57, Po0.001) groups.
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correlate of renal function, with kidneys supplied by
significant RAS showing no correlation between isoSK-GFR
and MPT or MCT. The strongest correlate of isoSK-GFR was
parenchymal volume, which is not unexpected as it
represents a 3D evaluation of the kidney rather than the
2D assessment provided by measurements of bipolar length
or parenchymal and cortical thicknesses. The adjustment of
cortical thickness measurements for the volume of the kidney
(estimated cortical mass), however, improved the strength of
the correlation with renal function. Furthermore, paren-
chymal volume was also found to be a more accurate diagnostic
marker of significant ARVD than either bipolar length or
cortical thickness. It is well known that renal morphology is
affected by body habitus and there are correlations of renal
length with height, and renal volume with height, weight, and
body surface area in normal subjects.27 In our study, no
differences were found in height, body mass index or surface
area between groups with differing renal artery anatomy.
Nevertheless, the significant differences between the groups
still existed after correction of the volume of the kidneys for
body mass index (renal volume index25).
An asymmetry in renal length, due to atrophy of kidneys
supplied by RAS, is commonly seen in patients with
ARVD.28,29 However, as shown in our study, changes in
renal length may not be as sensitive as other renal
morphological parameters in determining the presence of
intra-renal injury in early ARVD. Using spiral computed
tomography (CT) imaging, Mounier-Vehier et al.21 showed
that a significant decrease in cortical thickness with no
measurable difference in bipolar length was noted in kidneys
with RAS compared to those supplied by normal vessels,
suggesting that cortical parameters are more sensitive
markers for early ARVD diagnosis. The results from our
study support these findings, with significant reductions in
cortical thickness and parenchymal volume being associated
with significant RAS, with no significant difference in bipolar
length being observed. Statistically, our study showed
parenchymal volume to be a more sensitive marker of the
intra-renal changes due to significant RAS than MCT.
However, in this study, the MCT calculation was based on
three (upper, lateral, and lower measurements of cortical
thickness)24 rather than the six separate measurements used
by Mounier-Vehier et al.21
Full evaluation of renal morphology required the assess-
ment of mean medullary thickness (MMT). Interestingly, no
difference was observed in MMT between kidneys supplied
by significant RAS, insignificant RAS or normal vessels in this
study. This may be explained by physiological adaptive
mechanisms.30
Currently, there are no definite morphological or func-
tional parameters that can predict a successful renal
functional outcome after revascularization in ARVD, but
Table 1 | Morphological parameters and severity of renal artery stenosis
Normal RASo50% RASX50% RAO P-value
Number, n (%) 13 (20) 13 (20) 33 (50.8) 6 (9.2)
Renal function
isoSK-GFR (ml/min) mean7s.d.
(range)
29.29721.51 (4.68–85.10) 24.32721.72 (1.70–74.00) 14.08710.34a (2.80–41.20) 1.6170.97b, c (0.43–2.90) 0.001
Body size
Height (cm) mean7s.d. (range) 167.21710.44 (150.50–182.20) 168.0278.89 (153.70–182.20) 162.8477.76 (146.80–177.50) 158.2579.81 (146.80–168.40) 0.066
BMI (kg/m2) mean7s.d. (range) 26.8874.56 (20.67–33.61) 26.4474.23 (20.67–33.61) 25.3773.96 (18.40–32.24) 26.1073.64 (20.95–31.73) 0.680
Body surface area (m2)
mean7s.d. (range)
1.8470.27 (1.48–2.41) 1.8770.24 (1.52–2.41) 1.7570.21 (1.38–2.11) 1.6970.24 (1.45–2.08) 0.226
Renal morphology
Bipolar length (cm) mean7s.d.
(range)
9.8071.86 (5.0–12.6) 9.8271.50 (7.0–12.1) 8.7271.18 (6.8–11) 6.3371.40d (4.0–8.0) o0.001
Parenchymal volume (ml)
mean7s.d. (range)
179.24786.90 (33.78–337.09) 168.52776.40 (42.99–313.43) 120.65747.15a (51.65–220.04) 52.01738.07b, c (17.3–126.55) o0.001
MPT (mm) mean7s.d. (range) 19.6575.43 (10.67–30.0) 18.4274.22 (10.33–23.67) 16.3973.02 (7.67–22.2) 9.5673.94d (6.67–17.0) o0.001
MCT (mm) mean7s.d. (range) 7.2871.80 (4.67–10.33) 6.8672.2 (4.0–10.33) 5.6771.63a (2.67–8.67) 3.8371.44b (2.0–6.0) 0.002
MMT (mm) mean7s.d. (range) 12.3774.03 (6.0–19.67) 11.5673.60 (6.0–18.0) 10.7272.66 (5.0–15.43) 5.7273.13d (3.33–12.0) 0.001
Estimated cortical mass (ml)e
mean7s.d. (range)
67.24732.65 (14.78–112.56) 64.31737.14 (16.64–133.67) 42.44720.54a (12.59–90.67) 24.02723.79b, c (5.20–71.18) 0.002
Renal volume indexf mean7s.d.
(range)
6.7873.69 (1.38–16.31) 6.2872.72 (2.08–10.97) 4.6971.46a (1.94–8.19) 1.9171.12b, c (0.73–3.99) o0.001
Parenchymal volume/isoSK-GFR
ratio (ml per ml/min of GFR)
mean7s.d. (range)
10.1377.58 (3.51–37.26) 12.2877.77 (5.11–31.39) 0.290
aBetween normal and significant RAS groups.
bBetween normal and RAO groups.
cBetween insignificant and RAO groups.
dBetween RAO and all other groups.
eEstimated cortical mass: (cortical thickness/parenchymal thickness)parenchymal volume.
fRenal volume index:25 parenchymal volume adjusted for BMI (parenchymal volume/BMI).
Post-hoc analysis using conferroni correction: Po0.05.
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most clinicians use size as measured by bipolar length as one
of their guides. Smaller RAS kidneys (generally defined to be
less than 8 cm in length) are presumed to have extensive and
probable irreversible intra-renal damage, or are thought to
contribute little to overall renal function, and so are often not
subjected to revascularization procedures. Eleven of the 33
kidneys with significant RAS were defined as small in terms
of length; however, a number of these kidneys had a
parenchymal volume comparable to that of larger kidneys
(greater than 8 cm in length), again suggesting that bipolar
length may not be the most appropriate morphological
parameter to accurately assess renal size. Six of the 11 small
kidneys had isoSK-GFR greater than or equal to 7 ml/min;
these kidneys may not normally have been considered for
revascularization, but clearly, maintenance of their function
by preventing RAO and/or further renal atrophy could be
seen as beneficial to limiting the chances of progression to
end-stage renal disease in the future. Although decreases in
renal length, volume, parenchymal, and cortical thicknesses
are usually thought to reflect irreversible intra-renal damage,
there is evidence that some of the changes may be reversible
so deriving the concept of ‘hibernating parenchyma’.31 Hence,
there have been reports of increases in cortical and medullary
thicknesses occurring after revascularization of the RAS
kidney, suggesting the possibility of some reversibility of
parenchymal damage.32,33 Estimation of the parenchymal
volume to isoSK-GFR ratio in kidneys with significant RAS
provided support for the concept of ‘hibernating paren-
chyma’. A number of kidneys had a disproportionately greater
parenchymal volume: isoSK-GFR raising the possibility that
these were kidneys supplied by a hemodynamically signifi-
cant stenosis, yet without having undergone significant
Table 2 | Comparison of morphology in kidneys with significant RAS grouped according to size
o8 cm kidneys X8 cm kidneys P-value
Number, n (%) 11 (33.3) 22 (66.7)
Renal function
isoSK-GFR (ml/min) mean7s.d. (range) 8.4675.85 (2.80–20.50) 16.90711.03 (4.20–40.20) 0.024
Body size
Height (cm) mean7s.d. (range) 152.8076.09 (152.80–169.30) 164.2778.23 (146.80–177.50) 0.136
BMI (kg/m2) mean7s.d. (range) 24.5272.88 (19.61–28.77) 26.2173.83 (19.61–32.24) 0.084
Body surface area (m2) mean7s.d. (range) 1.6570.20 (1.38–1.93) 1.7970.20 (1.45–2.11) 0.054
Renal morphology
Bipolar length (cm) mean7s.d. (range) 7.5070.33 (6.80–7.90) 9.3270.95 (8.0–11.0) o0.001
Parenchymal volume (ml) mean7s.d. (range) 85.64724.98 (51.65–133.41) 138.08746.16 (71.50–220.04) 0.001
MPT (mm) mean7s.d. (range) 14.3572.85 (7.67–17.80) 17.4272.59 (12.33–22.20) 0.004
MCT (mm) mean7s.d. (range) 5.1871.89 (2.67–8.67) 5.9171.46 (3.50–8.67) 0.224
MMT (mm) mean7s.d. (range) 9.1772.79 (5.0–13.63) 11.5072.28 (7.33–15.43) 0.015
Estimated cortical mass (ml)a mean7s.d. (range) 30.96712.44 (12.59–50.89) 48.18721.59 (15.01–90.67) 0.021
aEstimated cortical mass: (cortical thickness/parenchymal thickness)parenchymal volume.
Table 3 | Morphological parameters of small kidneys with significant RAS grouped: isoSK-GFR o7 ml/min or X7 ml/min
isoSK-GFR o7 ml/min isoSK-GFR X7 ml/min P-value
Number, n (%) 5 (45.5) 6 (54.5)
Renal function
isoSK-GFR (ml/min) mean7s.d. (range) 3.7270.97 (2.80–5.0) 12.4072.10 (7.20–20.50) 0.005
Body size
Height (cm) mean7s.d. (range) 161.7678.28 (152.80–169.30) 158.4873.68 (154.10–162.80) 0.402
BMI (kg/m2) mean7s.d. (range) 24.3372.54 (22.71–28.77) 23.1574.82 (18.40–28.42) 0.636
Body surface area (m2) mean7s.d. (range) 1.6970.19 (1.50–1.93) 1.6170.22 (1.38–1.83) 0.528
Renal morphology
Parenchymal volume (ml) mean7s.d. (range) 82.57713.40 (68.53–104.21) 88.21713.50 (51.65–133.41) 0.730
MPT (mm) mean7s.d. (range) 14.6071.14 (13.33–16.33) 14.1373.88 (7.67–17.80) 0.802
MCT (mm) mean7s.d. (range) 4.8971.65 (3.0–7.0) 5.4272.20 (2.67–8.67) 0.671
MMT (mm) mean7s.d. (range) 9.7172.43 (7.33–13.33) 8.7273.22 (5.00–13.63) 0.586
Estimated cortical mass (ml)a mean7s.d. (range) 29.17714.76 (12.59–50.89) 32.45711.37 (17.96–49.82) 0.686
Parenchymal volume/ isoSK-GFR ratio (ml per
ml/min of GFR) mean7s.d. (range)
23.3576.83b (16.64–31.39) 7.6173.03 (5.11–13.03) 0.001
aEstimated cortical mass: (cortical thickness/parenchymal thickness)parenchymal volume.
bP=0.001 compared to normal/insignificant and significant RAS groups (see Table 1).
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irreversible renal structural change. This parenchymal
volume to isoSK-GFR ratio (or perhaps more accurately
cortical volume to isoSK-GFR ratio) has a potential use as a
prognostic indicator for revascularization.
This study demonstrates the superiority of 3D over 2D
measurements, in predicting isoSK-GFR, and this was
particularly noticeable in kidneys supplied by significant
RAS. Ultrasound estimations of renal morphology are
operator dependent and have been shown to be subject to
wide intra- and inter-observer variations;34 MRI has
provided a more accurate means of assessing renal morpho-
logy.20,35,36 Gadolinium-enhanced MRI can provide safe,
accurate evaluation of morphology, proximal arterial ana-
tomy, intra-renal hemodynamics, and estimations of single-
kidney function in research settings20,24,35,36 (Buckley DL
et al. Proceedings of the ISMRM 10th Annual Meeting, 2002;
abstract). The future clinical evaluation of ARVD in a one-
stop investigation is therefore becoming a real possibility. We
acknowledge that there are limitations in our investigative
protocol, which involves the use of a 1.0 T scanner with body
and spinal coils rather than a volume receiver coil. Never-
theless, we found that the presence of signal intensity
degradation was minimal with this protocol and that this
did not affect volume analysis using the voxel-count method
as all morphological analyses were performed in the coronal
plane.
This study demonstrates that the most sensitive morpho-
logical markers of both isoSK-GFR and significant RAS are
renal 3D volume measurements. The development and
progression of renal atrophy is known to occur in kidneys
with significant RAS, and the challenge remains to identify
those kidneys and intervene at a stage when ischemic changes
are still reversible or perhaps before they have even taken
place. Approximately 16% of all cases of ARVD are now
treated with renal revascularization procedures,37 and one
limitation of the current study is that the predictive value of
the MR investigative techniques was not tested in kidneys
undergoing renal revascularization. Adding assessment of
morphology to that of renal function may hold the key to the
appropriate selection of RAS kidneys that are most likely to
benefit from revascularization procedures. Further prospec-
tive studies will also reveal whether parenchymal volume:SK-
GFR analysis can help predict the renal functional response to
revascularization, the hypothesis being that kidneys with a
disproportionately high parenchymal volume:SK-GFR will be
those more likely to manifest improvement.
MATERIALS AND METHODS
Study population
Thirty-five patients with ARVD diagnosed by previous imaging
(intra-arterial digital subtraction, MR or CT angiography) were seen
consecutively in the renal clinics and consented to participation in
the study. The protocol had the approval of the Local Research
Ethics Committee. Basic patient demography and subsequent
clinical data were recorded. These included age, gender, height,
and weight.
Radioisotope single-kidney GFR
The assessment of individual kidney function involved a standard
radioisotopic methodology.26 In this, global GFR was first measured
with 51Cr-ethylenediaminetetraacetic acid clearance, and then
patients underwent 99mTc-dimercaptosuccinic acid scintigraphy
for the assessment of the differential static radioisotope uptake of
each kidney. The individual kidney function was calculated by
dividing the global GFR according to the percentage of the uptake of
99mTc-dimercaptosuccinic acid on scintigraphy. The isoSK-GFR was
unadjusted for surface area for correlation analysis with morpho-
logical parameters.
Magnetic resonance imaging
MR imaging was performed at 1.0 T (Magnetom Expert; Siemens
Medical Systems, Germany) using a combination of quadrature
body coil and spine coil for signal reception (no phased-array body
coil was available). Data were acquired for both structural and
functional analysis (Buckley DL et al. Proceedings of the ISMRM 10th
Annual Meeting 2002; abstract); only those images subsequently used
for the assessment of bipolar length, renal volume, parenchymal,
and cortical thickness are detailed below. Following the acquisi-
tion of scout images, the following sets of data were all obtained
during breath holds. Initially, images were acquired in the coronal
plane using a multislice TrueFISP sequence (field of view (FOV)¼
380 380 mm, 12 slices, slice thickness¼ 8 mm, gap¼ 4 mm,
matrix¼ 256 256, TR¼ 7.9 ms, TE¼ 3.7 ms, flip angle¼ 801).
Subsequently, 3D volume data were acquired using a FLASH
acquisition in the oblique–coronal plane encompassing both kidneys
and the descending aorta (TR¼ 5.4 ms, TE¼ 2.2 ms, FOV¼
350 306 80 mm, flip angle¼ 201, four signal averages, following
interpolation in the Fourier domain section thickness¼ 2.5 mm,
matrix¼ 128 112 32). Towards the end of the examination,
contrast-enhanced MRA (0.175 mmol/kg gadolinium diethylene-
triaminepentaacetic acid (Gd-DTPA)) was performed to assess
the proximal renal vasculature. Images were again obtained using a
3D-FLASH acquisition in the oblique–coronal plane (TR¼ 5.7 ms,
TE¼ 2.2 ms, FOV¼ 400 400 96 mm, flip angle¼ 301, following
interpolation in the Fourier domain section thickness¼ 2 mm,
matrix¼ 256 256 48). This sequence was repeated to provide
images in both the arterial and venous phases of the contrast agent
bolus transit.
The renal arterial anatomy was graded as normal vessel,
insignificant (o50%) RAS, significant (X50%) RAS or complete
occlusion (RAO). The kidney volumes were calculated from the 3D
volume images using the voxel-count method applied to coronal
MR images.35 In this method, the boundaries of the renal
parenchyma of each slice of the kidney were manually mapped.
The renal parenchymal volume was then calculated as follows:
Renal volumeðmlÞ ¼
X
ðparenchymal areaslice thicknessÞn slice
The 3D-MRA venous phase images were used for bipolar length and
cortical thickness analysis. The renal length was measured as the
difference between the superior pole and the inferior pole of the
kidney. The MPT was calculated from the trueFISP images; the
average of three measurements was taken from the superior (SPT),
lateral (LPT), and inferior (IPT) aspects of the kidney.24 Cortical
thickness was measured as the width of the high signal intensity
peripheral band on the 3D-MRA venous phase images. Three
measurements were taken from the superior (SCT), lateral (LCT),
and inferior (ICT) poles of the kidney. These were averaged and an
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MCT was obtained as follows:
MCT ðmmÞ ¼ ðSCT þ LCT þ ICTÞ=3
To give an estimate of total cortical mass, the total parenchymal
volume was multiplied by the ratio of MCT and MPT (estimated
cortical mass (ml)). MMT was calculated as
MMT ðmmÞ ¼
ððSPT þ LPT þ IPTÞ=3Þ  ðSCT þ LCT þ ICTÞ=3Þ
We have previously assessed the reproducibility and agreement of
these measurements of structural parameters. The agreement of
volume and cortical thickness measurements were R2¼ 0.96 and
0.80, respectively.
Body mass index was calculated from weight and height (weight
(kg)/height2 (m2)). Body surface area was calculated using the
Haycock formula as follows:38
Body surface area ðm2Þ ¼0:024265height ðcmÞ0:3964
weightðkgÞ0:5378
Evaluation criteria and statistical analysis
Kidneys supplied by completely occluded renal arteries were excluded
for correlation analysis between renal morphological parameters and
isoSK-GFR as it was assumed that their isoSK-GFR would be
negligible. Correlation subanalyses were performed on kidneys with
normal vessel or insignificant RAS and compared with kidneys
supplied by significant RAS so as to determine whether the isoSK-
GFR might be disproportionately low because of a hemodynamically
significant stenosis. Pearson’s correlation coefficient was used to test
the relationships between renal length, volume, parenchymal
thickness, cortical thickness, and isoSK-GFR. Parametric data are
presented as mean7standard deviation and grouped according to
severity of arterial stenosis, and renal morphology. Differences in
morphological parameters and isoSK-GFR between groups were
compared by the use of analysis of variance and post hoc analysis
using Bonferroni correction. Significance level was set at 5%. SPSS
software was used for all statistical analysis.
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